XYXue Yang

Xue Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xue Yang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Adaptive Multiphase Liver Tumor Segmentation With Multiscale Supervision

    by Haopeng Kuang, Xue Yang, Hongjun Li, Jingwei Wei, Lihua Zhang

    The segmentation of liver tumors using multi-phase computed tomography (CT) images has garnered considerable attention in medical signal processing. However, existing multi-phase liver tumor segmentation methods primarily concentrate on feature integration across various phases, neglecting a comprehensive exploration of synergistic relationships among these phases and constraints on features across different scales. This limitation has led to performance bottlenecks in existing approaches. This article proposes a robust multi-phase liver tumor segmentation framework designed to address the aforementioned challenges. Specifically, we introduce a novel multi-phase and channel-stacked dual attention module, seamlessly integrated within a multi-scale architecture. This module adaptively captures essential semantic information among different phases, enhancing the segmentation network's feature extraction capabilities. A scale-weighted loss function for multi-scale supervision is also designed to mitigate false positives in the segmentation results. To facilitate a systematic evaluation of our model's performance on multi-phase data, we curate a new dataset comprising samples from four distinct phases. Our proposed framework is rigorously assessed through comprehensive quantitative and qualitative experiments, highlighting its compelling performance.


  • Open Access

    Diagnostic value of chest computed tomography imaging for COVID-19 based on reverse transcription-polymerase chain reaction: a meta-analysis

    by Jing Liu, Xue Yang, Yunxian Zhu, Yi Zhu, Jingzhe Liu, Xiantao Zeng, Hongjun Li

    Background: The computed tomography (CT) diagnostic value of COVID-19 is controversial. We summarized the value of chest CT in the diagnosis of COVID-19 through a meta-analysis based on the reference standard. Methods: All Chinese and English studies related to the diagnostic value of CT for COVID-19 across multiple publication platforms, was searched for and collected. Studies quality evaluation and plotting the risk of bias were estimated. A heterogeneity test and meta-analysis, including plotting sensitivity (Sen), specificity (Spe) forest plots, pooled positive likelihood ratio (+LR), negative likelihood ratio (-LR), dignostic odds ratio (DOR) values and 95% confidence interval (CI), were estimated. If there was a threshold effect, summary receiver operating characteristic curves (SROC) was further plotted. Pooled area under the receiver operating characteristic curve (AUROC) and 95% CI were also calculated. Results: Twenty diagnostic studies that represented a total of 9004 patients were included from 20 pieces of literatures after assessing all the aggregated studies. The reason for heterogeneity was caused by the threshold effect, so the AUROC = 0.91 (95% CI: 0.89–0.94) for chest CT of COVID-19. Pooled sensitivity, specificity, +LR, -LR from 20 studies were 0.91 (95% CI: 0.88–0.94), 0.71 (95% CI: 0.59–0.80), 3.1(95% CI: 2.2–4.4), 0.12 (95% CI: 0.09–0.17), separately. The I2 was 85.6% (P = 0.001) by Q-test. Conclusions: The results of this study showed that CT diagnosis of COVID-19 was close to the reference standard. The diagnostic value of chest CT may be further enhanced if there is a unified COVID-19 diagnostic standard. However, please pay attention to rational use of CT. Graphic